Turkey approves emergency use of Sputnik V vaccine

Health Minister says approval paves the way for use of Russia’s Sputnik V vaccine alongside Sinovac and the Pfizer vaccines.

ANKARA - Turkish authorities have granted Russia’s Sputnik V vaccine approval for its emergency use in Turkey, Health Minister Fahrettin Koca announced Friday.

Koca said on Twitter the Turkish Pharmaceuticals and Medical Devices Agency approved the vaccine’s emergency use following its “examinations and evaluations,” paving the way for use alongside Sinovac and the Pfizer vaccines.

It was not known when the country will begin administering the vaccine. Koca said this week Turkey would receive 50 million doses of the Sputnik V shots within the next six months.

Russian Direct Investment Fund recently signed an agreement with Turkish biopharmaceutical company Viscoran Ilac to begin producing its Sputnik V vaccine in Turkey. Viscoran aims to start production in the coming months in several facilities, the company said.

Turkey, a nation of 84 million, says it has administered some 22.8 million doses since it rolled out its vaccination program in mid-January. About 9 million people have been fully vaccinated.